Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

66.58
-0.3700-0.55%
Post-market: 66.47-0.1103-0.17%19:55 EDT
Volume:5.54M
Turnover:368.73M
Market Cap:135.54B
PE:14.66
High:66.84
Open:66.77
Low:66.19
Close:66.95
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.82
T/O Rate:0.27%
Dividend:2.51
Dividend Rate:3.77%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:6.07
PE(LYR):19.24

Loading ...

Procter & Gamble, Target, Canopy, Bristol, Oklo Insider Shock

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Sweden's Elicera Therapeutics Q2 Loss Widens

Reuters
·
Aug 28

Bristol-Myers Squibb Extends Deucravacitinib Program, Signaling Long-Term Autoimmune Ambitions

TIPRANKS
·
Aug 28

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

Top Bristol-Myers Squibb Executive Makes Notable Move With Recent Stock Sale

TIPRANKS
·
Aug 27

Bristol Myers Squibb SVP, Controller Phil M. Holzer Sells 500 Shares for $33,750

Reuters
·
Aug 27

Bloomsbury Ties Executive Share Awards to Long-Term Performance Targets

TIPRANKS
·
Aug 26

Bristol Myers Squibb Stock (BMY) Looks Healthier After Ditching Blood Cancer Partner

TIPRANKS
·
Aug 26

Bristol Myers Ends Blood Cancer Drug Deal with Cell Therapy Maker Cellares

Reuters
·
Aug 26

Confirm That We Have Ended Our Partnership with Cellares. - Bristol Myers Spokesperson

THOMSON REUTERS
·
Aug 25

Bristol Myers Spokesperson: Determined Cellares-Partnered Cell Shuttle System Could not Meet Necessary Requirements to Make Commercial Breyanzi

THOMSON REUTERS
·
Aug 25

Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story

TIPRANKS
·
Aug 22

Movement Alert|Bristol-Myers Squibb Rises 3.02% in Regular Trading, AI Antibody R&D Partnership and Sector Strength Fuel Rally

Market Focus
·
Aug 21

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.17% on Aug 20: Facts Behind the Movement

TradingKey
·
Aug 21

Movement Alert|Bristol-Myers Squibb Falls 3.03% in Regular Trading, Pharmaceutical Sector Broadly Under Pressure

Market Focus
·
Aug 21

Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress

TIPRANKS
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Chai Discovery Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery

Reuters
·
Aug 20